e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The management of non-CF bronchiectasis in Europe: data from the European Bronchiectasis Network
James D. Chalmers (Perth, United Kingdom)
Source:
International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)
Session:
Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)
Session type:
Symposium
Number:
2882
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
James D. Chalmers (Perth, United Kingdom). The management of non-CF bronchiectasis in Europe: data from the European Bronchiectasis Network. International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
ERS clinical practice guidelines on bronchiectasis in children
Related content which might interest you:
Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016
Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
Phenotyping of adult patients with bronchiectasis and Yellow-Nail-Syndrome (YNS)- data from the German and the European Bronchiectasis Registries (PROGNOSIS and EMBARC)
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Research priorities in bronchiectasis: A consensus from the European multicentre bronchiectasis audit and research collaboration (EMBARC) study group
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015
Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018
Long term clinical outcomes of bronchiectasis in India: Data from the EMBARC/RRNI Indian Bronchiectasis Registry
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021
New isolation of non-tuberculous mycobacteria in patients with bronchiectasis - data from the European Bronchiectasis Registry (EMBARC)
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Challenges in the management of non-CF bronchiectasis
Source: International Congress 2016 – Challenges in the management of non-CF bronchiectasis
Year: 2016
Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Mucus clearance devices in bronchiectasis: Indian experience
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
Treatment of patients with idiopathic pulmonary fibrosis in real-life setting: Results from the Latin American Pulmonary Fibrosis Registry REFIPI
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
European Respiratory Society guidelines for the management of adult bronchiectasis
Source: Guideline 2017
Year: 2017
European Respiratory Society guidelines for the management of adult bronchiectasis
Source: Eur Respir J, 50 (3) 1700629; 10.1183/13993003.00629-2017
Year: 2017
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network
Source: Eur Respir J, 51 (1) 1701937; 10.1183/13993003.01937-2017
Year: 2018
Clinical cases: COPD and bronchiectasis
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018
Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies?
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
The microbiology of stable bronchiectasis: data from the EMBARC bronchiectasis registry
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept